Chemotherapy-related magnetic resonance imaging abnormalities mimicking disease progression following intraventricular liposomal cytarabine and high dose methotrexate for neurolymphomatosis. uri icon

Overview

publication date

  • February 13, 2012

Research

keywords

  • Antineoplastic Agents
  • Cytarabine
  • Magnetic Resonance Imaging
  • Methotrexate
  • Nervous System Diseases

Identity

Scopus Document Identifier

  • 84864234379

Digital Object Identifier (DOI)

  • 10.3109/10428194.2012.656632

PubMed ID

  • 22242822

Additional Document Info

volume

  • 53

issue

  • 8